Skip to search formSkip to main contentSkip to account menu

FDX104 Antibiotic Foam

Known as: FDX104 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Safety and activity of topical 4% doxycycline foam (FDX104) in epidermal growth factor receptor inhibitor (EGFRI) induced skin toxicity.
10130Background: Painful and pruritic acneiform rash is a common treatment-limiting side effect of antibody and small molecule… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)